BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8113421)

  • 1. Transforming growth factor-beta activation in irradiated murine mammary gland.
    Barcellos-Hoff MH; Derynck R; Tsang ML; Weatherbee JA
    J Clin Invest; 1994 Feb; 93(2):892-9. PubMed ID: 8113421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation-induced transforming growth factor beta and subsequent extracellular matrix reorganization in murine mammary gland.
    Barcellos-Hoff MH
    Cancer Res; 1993 Sep; 53(17):3880-6. PubMed ID: 8358713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of active transforming growth factor-beta in situ using engineered tissue.
    Barcellos-Hoff MH; Ehrhart EJ; Kalia M; Jirtle R; Flanders K; Tsang ML
    Am J Pathol; 1995 Nov; 147(5):1228-37. PubMed ID: 7485387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent transforming growth factor beta1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation.
    Ehrhart EJ; Segarini P; Tsang ML; Carroll AG; Barcellos-Hoff MH
    FASEB J; 1997 Oct; 11(12):991-1002. PubMed ID: 9337152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical localization of latent transforming growth factor-beta1 activation by stimulated macrophages.
    Chong H; Vodovotz Y; Cox GW; Barcellos-Hoff MH
    J Cell Physiol; 1999 Mar; 178(3):275-83. PubMed ID: 9989773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic activation of latent TGF-beta precedes caspase-3 activation and enhances apoptotic death of lung epithelial cells.
    Solovyan VT; Keski-Oja J
    J Cell Physiol; 2006 May; 207(2):445-53. PubMed ID: 16447253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
    Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
    Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
    Ghahary A; Tredget EE; Mi L; Yang L
    Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of transforming growth factor-beta isoforms by embryonic stem cells: isoform and latency are dependent on direction of differentiation.
    Slager HG; Freund E; Buiting AM; Feijen A; Mummery CL
    J Cell Physiol; 1993 Aug; 156(2):247-56. PubMed ID: 8344983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent transforming growth factor-beta is present in the extracellular matrix of embryonic hearts in situ.
    Ghosh S; Brauer PR
    Dev Dyn; 1996 Feb; 205(2):126-34. PubMed ID: 8834473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dexamethasone on the expression of transforming growth factor-beta in mouse embryonic palatal mesenchymal cells.
    Potchinsky M; Nugent P; Lafferty C; Greene RM
    J Cell Physiol; 1996 Feb; 166(2):380-6. PubMed ID: 8591998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maspin is involved in bone matrix maturation by enhancing the accumulation of latent TGF-beta.
    Tokuyama R; Satomura K; Maeda E; Kudoh K; Yamasaki Y; Nagayama M
    J Bone Miner Res; 2007 Oct; 22(10):1581-91. PubMed ID: 17563239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particular types of tumor cells have the capacity to convert transforming growth factor beta from a latent to an active form.
    Takiuchi H; Tada T; Li XF; Ogata M; Ikeda T; Fujimoto S; Fujiwara H; Hamaoka T
    Cancer Res; 1992 Oct; 52(20):5641-6. PubMed ID: 1327512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
    Ghahary A; Tredget EE; Shen Q
    J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased transforming growth factor beta expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells.
    Chang HL; Gillett N; Figari I; Lopez AR; Palladino MA; Derynck R
    Cancer Res; 1993 Sep; 53(18):4391-8. PubMed ID: 8364935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-binding proteins mediate TGF-beta 1-induced apoptosis in bovine mammary epithelial BME-UV1 cells.
    Gajewska M; Motyl T
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):65-75. PubMed ID: 15556067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.
    Bandyopadhyay A; Zhu Y; Cibull ML; Bao L; Chen C; Sun L
    Cancer Res; 1999 Oct; 59(19):5041-6. PubMed ID: 10519421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and progesterone regulate radiation-induced p53 activity in mammary epithelium through TGF-beta-dependent pathways.
    Becker KA; Lu S; Dickinson ES; Dunphy KA; Mathews L; Schneider SS; Jerry DJ
    Oncogene; 2005 Sep; 24(42):6345-53. PubMed ID: 15940247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
    Odekon LE; Blasi F; Rifkin DB
    J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression and biological activity of retinoic acid-induced TGFbeta isoforms in embryonic palate mesenchymal cells.
    Nugent P; Ma L; Greene RM
    J Cell Physiol; 1998 Oct; 177(1):36-46. PubMed ID: 9731743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.